Luigi Mangione To Pursue Psychiatric Defense In UnitedHealthcare CEO Murder Trial

Luigi Mangione will pursue a psychiatric defense in his upcoming trial over the killing of UnitedHealthcare CEO Brian Thompson, with a Manhattan judge revealing that his legal team plans to argue he was suffering from an “extreme emotional disturbance” at the time of the shooting.

During a court hearing Wednesday, Manhattan Supreme Court Judge Gregory Carro said Mangione’s attorneys intend to argue that he was in the throes of an extreme emotional disturbance when prosecutors say he gunned down Thompson in December 2024.

If successful, the legal strategy could reduce the charge from murder to manslaughter, significantly lowering the potential prison sentence if jurors accept the defense.

The precise nature of Mangione’s alleged psychiatric issues was not immediately disclosed in court. Judge Carro said prosecutors are entitled to know the basis of the defense and ordered Mangione’s attorneys to provide additional details.

“They need to know what the malady this defendant suffers and how that triggered extreme emotion disturbance at the time of the occurrence,” Carro said during the hearing.

The judge ordered the defense team to provide the Manhattan District Attorney’s Office with more information by Thursday, including details about the alleged condition and how it purportedly led to Thompson being targeted.

Mangione is scheduled to stand trial on Sept. 8 in Manhattan, where prosecutors are expected to argue that the killing was a deliberate and calculated act.

The case has drawn national attention due to the high-profile nature of the victim and the unusual defense strategy now being pursued by Mangione’s legal team.

The psychiatric defense sets the stage for what is expected to be a closely watched courtroom battle over Mangione’s mental state and whether jurors believe he was suffering from an extreme emotional disturbance at the time of the fatal shooting.